<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" xml:lang="en">

    <title type="text">News - Press releases</title>
    <subtitle type="text">News - Press releases:</subtitle>
    <link rel="alternate" type="text/html" href="/news/press/" />
    
    <updated>2013-06-10T13:09:51Z</updated>
    <rights>Copyright (c) 2013, Admin</rights>
    <generator uri="http://expressionengine.com/" version="1.7.3">ExpressionEngine</generator>
    <id>tag:,2013:06:10</id>


    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/otcsafety-spanish" /><feedburner:info uri="otcsafety-spanish" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:browserFriendly></feedburner:browserFriendly><entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-consumers-wanted-to-report-product-problems/" />
      <id>tag:,2013:/news/press/5.1554</id>
      <published>2013-06-10T13:09:50Z</published>
      <updated>2013-06-10T13:09:51Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-allergy-meds-could-affect-your-driving/" />
      <id>tag:,2013:/news/press/5.1548</id>
      <published>2013-06-03T19:29:57Z</published>
      <updated>2013-06-03T19:37:58Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-users-of-last-cfc-inhalers-must-soon-switch/" />
      <id>tag:,2013:/news/press/5.1547</id>
      <published>2013-05-29T18:13:32Z</published>
      <updated>2013-05-29T18:18:33Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-otc-nicotine-replacement-therapy-nrt-labels-may-change/" />
      <id>tag:,2013:/news/press/5.1543</id>
      <published>2013-04-02T21:00:00Z</published>
      <updated>2013-04-30T20:21:01Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-know-the-active-ingredients-in-your-childrens-medicines/" />
      <id>tag:,2013:/news/press/5.1538</id>
      <published>2013-03-14T21:19:23Z</published>
      <updated>2013-04-30T20:22:24Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-what-consumers-should-know-about-triclosan/" />
      <id>tag:,2013:/news/press/5.1537</id>
      <published>2013-03-07T23:40:36Z</published>
      <updated>2013-04-30T20:25:37Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-people-seek-information-about-hemorrhoids/" />
      <id>tag:,2013:/news/press/5.1535</id>
      <published>2013-02-12T20:26:17Z</published>
      <updated>2013-04-30T20:26:18Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-news-alert-dont-double-up-on-acetaminophen-this-flu-season/" />
      <id>tag:,2013:/news/press/5.1532</id>
      <published>2013-01-24T21:21:26Z</published>
      <updated>2013-01-24T21:27:27Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/new-research-shows-negative-interactions-between-grapefruit-and-certain-med/" />
      <id>tag:,2012:/news/press/5.1528</id>
      <published>2012-11-27T21:37:48Z</published>
      <updated>2012-11-27T21:39:49Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-warns-parents-to-safely-store-otc-eye-drops-and-nasal-sprays-out-of-chi/" />
      <id>tag:,2012:/news/press/5.1523</id>
      <published>2012-10-25T21:22:54Z</published>
      <updated>2012-10-25T21:24:55Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title />
      <link rel="alternate" type="text/html" href="/news/press/fda-consumer-updates-on-topical-pain-relievers/" />
      <id>tag:,2012:/news/press/5.1476</id>
      <published>2012-09-13T21:34:33Z</published>
      <updated>2012-09-13T21:42:34Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title>News Regarding OTC Products Containing Benzocaine</title>
      <link rel="alternate" type="text/html" href="/news/press/news-regarding-otc-products-containing-benzocaine-12/" />
      <id>tag:,2012:/news/press/5.1270</id>
      <published>2012-05-31T19:37:06Z</published>
      <updated>2012-06-19T15:01:07Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    
              ]]></content>
    </entry>

    <entry>
      <title>FDA Drug Safety Communication: Infants' Liquid Acetaminophen</title>
      <link rel="alternate" type="text/html" href="/news/external/fda-alert-concentration-of-liquid-acetaminophen-marketed-for-infants/" />
      <id>tag:,2011:/news/external/4.994</id>
      <published>2011-12-27T15:50:51Z</published>
      <updated>2012-03-12T15:06:52Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    The U.S. Food and Drug Administration (FDA) is informing the public that an additional concentration of liquid acetaminophen marketed for "infants" (160 mg/5 mL) is now available at local stores. Until now, liquid acetaminophen marketed for infants was only available in 80 mg/0.8 mL or 80 mg/mL concentrations. This change in the concentration will affect the amount of liquid given to an infant, and should be especially noted if someone is accustomed to using the 80 mg /0.8 mL or 80 mg/mL concentrations of liquid acetaminophen. <br><br>

In addition to this change in concentration, this product may also be packaged with an oral syringe instead of a dropper. <br><br>
              ]]></content>
    </entry>

    <entry>
      <title>Changes in Labeling for Children’s Pain Reliever (via Parenting Squad)</title>
      <link rel="alternate" type="text/html" href="/news/external/changes-in-labeling-for-childrens-pain-reliever-via-parenting-squad/" />
      <id>tag:,2011:/news/external/4.953</id>
      <published>2011-11-17T19:56:09Z</published>
      <updated>2012-03-12T15:07:10Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    When your child wakes up in the middle of the night crying with a fever, you need to have the right kind of medication on hand and know the correct dosage that your child requires to start feeling better. In the past, it could be quite confusing because infants' (under age 2) liquid acetaminophen was made in a concentrated form that required a smaller dose, while children's (ages 2 and up) liquid medication was not concentrated and required a whole different level of dosing. If you made a mistake and mixed up the two bottles (so easy to do at 2 a.m. when you are exhausted and not seeing straight), you could easily give too much or too little medication — a potentially dangerous situation.

Fortunately, manufacturers of these children's medications realized that this situation was confusing and potentially harmful, and have made voluntary and self-initiated changes to make all of this a lot simpler for parents.
              ]]></content>
    </entry>

    <entry>
      <title>What Parents Need to Know About Infant and Children’s Acetaminophen (via Kiddie Corner Deals)</title>
      <link rel="alternate" type="text/html" href="/news/external/what-parents-need-to-know-about-infant-and-childrens-acetaminophen/" />
      <id>tag:,2011:/news/external/4.921</id>
      <published>2011-10-31T14:33:24Z</published>
      <updated>2012-03-12T15:07:25Z</updated>
      <author>
            <name>Admin</name>
            <email>chris.broomall@edelman.com</email>
                  </author>
      <content type="html"><![CDATA[
                    Changes have been made to all single-ingredient liquid infant’s and children’s acetaminophen only and do not apply to solid, single-ingredient acetaminophen or multi-symptom treatments that contain acetaminophen. But why have they made these changes? To make it easier for parents and caregivers to use the medicines and to reduce medical errors including overdosing. They have also included a better safety feature on the new infant and children’s acetaminophen bottles. They are now equipped with flow restrictors so if a child were to accidentally get a hold of a bottle of the medicine a minimal amount will leave the bottle.
              ]]></content>
    </entry>


</feed>
